A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
收藏DataCite Commons2025-07-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008973/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin
degludec on blood sugar levels in participants with type 2 diabetes. The study will last
about 67 weeks and may include up to 22 visits.
提供机构：
Vivli
创建时间：
2023-05-26
